Once a pharmaceutical buys a licence, how are you going to stop them from what you might call “exploitation”, although they would just call “profitability”?
On October 18th, 2018. See this statement in context.
On October 18th, 2018. See this statement in context.
October 18th, 2018 / 10:30 a.m.
Chatham-Kent—Leamington, CPC
Once a pharmaceutical buys a licence, how are you going to stop them from what you might call “exploitation”, although they would just call “profitability”?
See context to find out what was said next.